De-identified Health Data Market Size to Hit USD 20.79 Billion by 2035 | SNS Insider
The U.S. De-identified Health Data Market is projected to reach USD 5.24 Billion and Europe USD 5.65 Billion by 2035, driven by AI, real-world evidence, and privacy-compliant data demand.
Austin, United States, Aug. 18, 2026 (GLOBE NEWSWIRE) — The De-identified Health Data Market Size was valued at USD 8.52 Billion in 2025 and is projected to reach USD 20.79 Billion by 2035, growing at a CAGR of 9.32% during 2026–2035, according to a new report by SNS Insider. Increasing use of artificial intelligence in the healthcare industry, increasing requirement of real-world evidence, and growing necessity for privacy compliant healthcare data sets are driving the market growth.
The De-identified Health Data Market is growing as health care providers, drug makers, scientists, and tech firms create and analyze larger amounts of electronic health records and other patient data. With de-identification, it becomes possible to strip out protected health information and personally identifiable information from health care data, allowing its usage in research, analytics, machine learning, and other applications while meeting privacy considerations.
Download the De-identified Health Data Market Sample Report: https://www.snsinsider.com/sample-request/8075
AI and Real-World Evidence Drive De-identified Health Data Market Growth
De-identified health records are gaining more significance due to the advancements in areas such as artificial intelligence, real-world evidence gathering, and health care research through data-driven methods. AI companies in the health care industry need big data sets to build their diagnosis and clinical decision support systems, and pharmaceutical/biotech organizations are increasingly relying on de-identified data for health care purposes.
De-identified Health Data Market Key Takeaways
- Leading Data Type: Clinical Data, with a 20.60% market share in 2025.
- Leading Application: Clinical Research and Trials, accounting for 25.62% of revenue in 2025.
- Leading End User: Healthcare Providers.
- Largest Regional Market: North America, with a 39.70% share in 2025.
- Fastest-Growing Region: Asia Pacific.
- Leading Country Market: The U.S., accounting for approximately 83% of North American market revenue.
North America Leads the De-identified Health Data Market While Asia Pacific Registers the Fastest Growth
North America was the dominating player in the De-identified Health Data Market by accounting for 39.70% of the total revenue in 2025. Factors that have enabled North America’s dominance include its robust electronic health records environment, a well-built health care data infrastructure, robust de-identification and privacy standards, and high demand from pharmaceuticals, biotech companies, and health care technologies firms.
The U.S. De-identified Health Data Market was valued at USD 2.12 Billion in 2025 and is projected to reach USD 5.24 Billion by 2035, growing at a CAGR of 9.46%. Factors contributing towards the growth of the market include well-developed EHR environment, solid health data ecosystem, HIPAA privacy concerns, and the growing need for real-world evidence and precision medicine.
The Europe De-identified Health Data Market was valued at USD 2.39 Billion in 2025 and is projected to reach USD 5.65 Billion by 2035, expanding at a CAGR of 8.96%. The driving forces behind market growth include advancements in health data infrastructure, development of privacy-oriented data governance framework, and increasing use of real-world evidence in pharmaceuticals and academia.
Asia-Pacific is expected to witness the highest growth rate for the De-identified Health Data Market owing to the rising digital transformation in the healthcare industry, government measures promoting health information exchanges, significant investments in genomic and precision medicine, and extensive drug development activities in China, India, Japan, and South Korea.
De-identified Health Data Market Segmentation Analysis
By Type of Data: The Clinical Data had a market share of around 20.60% in 2025 due to the extensive use of EHRs and the significance of information such as diagnoses, medications, treatments, lab results, vitals, imaging reports, and clinical notes in studies and treatment development, managing the health of the population, and AI model training. The Behavioral and Patient-Reported Data is forecasted to grow the fastest in the period up to 2035 due to rising use of digital health monitoring systems, wearable sensors, mobile health applications, and remote patient monitoring solutions.
By Application: Clinical Research and Trials constituted the highest market share of around 25.62% in 2025 due to rising utilization of de-identified real-world data for feasibility analysis of clinical trials, cohort identification, comparator arm development, safety signal generation, and post-marketing surveillance. Drug Discovery and Development are estimated to be the fastest growing application due to rising popularity of AI-enabled drug discovery and rising demand for de-identified molecular, genomic, proteomic, and clinical data.
By End User: The Healthcare Providers dominated the market in 2025 owing to the fact that they served as important producers and consumers of the de-identified health information in making clinical decisions and conducting research and quality improvement initiatives. On the other hand, the Pharmaceutical Companies are projected to have the highest growth rate during the forecast period till 2035 on account of the use of de-identified real-world data for developing drugs and conducting clinical trials.
Explore the Complete De-identified Health Data Market Report: https://www.snsinsider.com/reports/de-identified-health-data-market-8075
Leading Market Players Listed in this Report are:
- IQVIA Holdings Inc.
- Oracle Health (Cerner Corporation)
- Merative (IBM Watson Health)
- Optum Inc. (UnitedHealth Group)
- Veradigm LLC
- HealthVerity Inc.
- Truveta Inc.
- Komodo Health Inc.
- Clarify Health Solutions Inc.
- Tempus Labs Inc.
- Flatiron Health Inc.
- H1 Insights Inc.
- TriNetX LLC
- Aetion Inc.
- Verantos Inc.
- Privacy Analytics Inc. (IQVIA)
- Mendel.ai Inc.
- Datavant Inc.
- Nference Inc.
- SAS Institute Inc.
Recent Developments:
- February 2025: Veradigm introduced disease-specific Cardiometabolic Clinical Data Registry datasets containing de-identified patient health and treatment data to accelerate clinical research and improve patient outcomes.
- October 2025: Epic Systems announced developer tools and interoperability upgrades, including API improvements and data exchange functionality supporting cloud-based workflows and broader access to research datasets.
Frequently Asked Questions (FAQs):
What is the projected size of the De-identified Health Data Market by 2035?
The market is projected to reach USD 20.79 Billion by 2035.
What was the De-identified Health Data Market size in 2025?
The market was valued at USD 8.52 Billion in 2025.
What is the CAGR of the De-identified Health Data Market?
The market is projected to grow at a CAGR of 9.32% during 2026–2035.
Which region dominates the De-identified Health Data Market?
North America led the market with a 39.70% revenue share in 2025.
Which application holds the largest market share?
Buy the De-identified Health Data Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/8075
De-identified Health Data Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 8.52 Billion |
| Market Size by 2035 | USD 20.79 Billion |
| CAGR | CAGR of 9.32% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Type of Data (Clinical Data, Claims and Billing Data, Pharmaceutical and R&D Data, Genomic and Molecular Data, Behavioral and Patient-Reported Data, Others) • By Application (Clinical Research and Trials, Drug Discovery and Development, Population Health Management, AI and ML Model Training, Value-Based Care and Quality Improvement, Others) • By End-User (Pharmaceutical Companies, Healthcare Providers, Health Insurance and Payers, Biotechnology Firms, Academic and Research Institutions, Government and Regulatory Agencies, Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
Healthcare Data Storage Market Size 2026
Healthcare IT Integration Market Growth 2026
Electronic Health Record (EHR) Apps Market Trends 2026
Electronic Health Records (EHR) Market Outlook 2026
Electronic Medical Record (EMR) Systems Market Size 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
